Corporate activity in the healthcare sector is heating up. GlaxoSmithKline ( GSK ) and US rival Pfizer plan to marry their consumer health businesses in a £10bn joint venture. Bristol-Myers Squibb has made a $74bn takeover offer for Celgene and Eli Lily is to pay $8bn for Loxo Oncology. Analysts are confident the mergers and acquisitions (M&A) trend still has legs in the sector and many believe there are...
Want to read more?
Full access to digital Shares magazine is available to AJ Bell Youinvest customers with account balances of £4,000 or more
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.